Selective resistance of CD44hi T cells to p53-dependent cell death results in persistence of immunologic memory after total body irradiation

Journal of Immunology

Volumn 187, Issue 8, 2011, Pages 4100-4108

  Yao, Zhenyu ^a   Jones, Jennifer ^a   Kohrt, Holbrook ^a   Strober, Samuel ^a  

^a STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIGEN; HERMES ANTIGEN; PROTEIN BCL 2; PROTEIN P53; CD44 PROTEIN, MOUSE;

ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; BONE MARROW TRANSPLANTATION; CD4+ T LYMPHOCYTE; CD8+ T LYMPHOCYTE; CELL DEATH; CELL DIFFERENTIATION; CONTROLLED STUDY; IMMUNOLOGICAL MEMORY; MALE; MEMORY T LYMPHOCYTE; MOUSE; NATURAL KILLER T CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RADIOSENSITIVITY; T LYMPHOCYTE; WHOLE BODY RADIATION; ANIMAL; C57BL MOUSE; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGY; METABOLISM; MOUSE MUTANT; RADIATION EXPOSURE; T LYMPHOCYTE SUBPOPULATION;

ANIMALS; ANTIGENS, CD44; CELL DEATH; CELL SEPARATION; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; IMMUNOLOGIC MEMORY; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; T-LYMPHOCYTE SUBSETS; TUMOR SUPPRESSOR PROTEIN P53; WHOLE-BODY IRRADIATION;

EID: 80054720492     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1101141     Document Type: Article

References (33)

1. Baron, F., R. Storb, B. E. Storer, M. B. Maris, D. Niederwieser, J. A. Shizuru, T. R. Chauncey, B. Bruno, S. J. Forman, P. A. McSweeney, et al. 2006. Factors associated with outcomes in allogeneic hematopoietic cell transplantation with nonmyeloablative conditioning after failed myeloablative hematopoietic cell transplantation. J. Clin. Oncol. 24: 4150-4157. (Pubitemid 46622292)
2. Mielcarek, M., P. J. Martin, W. Leisenring, M. E. Flowers, D. G. Maloney, B. M. Sandmaier, M. B. Maris, and R. Storb. 2003. Graft-versus-host disease after nonmyeloablative versus conventional hematopoietic stem cell transplantation. Blood 102: 756-762. (Pubitemid 36842003)
3. McSweeney, P. A., D. Niederwieser, J. A. Shizuru, B. M. Sandmaier, A. J. Molina, D. G. Maloney, T. R. Chauncey, T. A. Gooley, U. Hegenbart, R. A. Nash, et al. 2001. Hematopoietic cell transplantation in older patients with hematologic malignancies: replacing high-dose cytotoxic therapy with graft-versus-tumor effects. Blood 97: 3390-3400.
4. Maris, M. B., B. M. Sandmaier, B. E. Storer, T. Chauncey, M. J. Stuart, R. T. Maziarz, E. Agura, A. A. Langston, M. Pulsipher, R. Storb, and D. G. Maloney. 2004. Allogeneic hematopoietic cell transplantation after fludarabine and 2 Gy total body irradiation for relapsed and refractory mantle cell lymphoma. Blood 104: 3535-3542. (Pubitemid 39564424)
5. Niederwieser, D., M. Maris, J. A. Shizuru, E. Petersdorf, U. Hegenbart, B. M. Sandmaier, D. G. Maloney, B. Storer, T. Lange, T. Chauncey, et al. 2003. Low-dose total body irradiation (TBI) and fludarabine followed by hematopoietic cell transplantation (HCT) from HLA-matched or mismatched unrelated donors and postgrafting immunosuppression with cyclosporine and mycophenolate mofetil (MMF) can induce durable complete chimerism and sustained remissions in patients with hematological diseases. Blood 101: 1620-1629. (Pubitemid 36182543)
6. Valcárcel, D., R. Martino, D. Caballero, J. Martin, C. Ferra, J. B. Nieto, A. Sampol, M. T. Bernal, J. L. Piñana, L. Vazquez, et al. 2008. Sustained remissions of high-risk acute myeloid leukemia and myelodysplastic syndrome after reduced-intensity conditioning allogeneic hematopoietic transplantation: chronic graft-versus-host disease is the strongest factor improving survival. J. Clin. Oncol. 26: 577-584. (Pubitemid 351264351)
7. Champlin, R. E., M. M. Horowitz, D. W. van Bekkum, B. M. Camitta, G. E. Elfenbein, R. P. Gale, E. Gluckman, R. A. Good, A. A. Rimm, C. Rozman, et al. 1989. Graft failure following bone marrow transplantation for severe aplastic anemia: risk factors and treatment results. Blood 73: 606-613. (Pubitemid 19060551)
8. Walters, M. C., M. Patience, W. Leisenring, J. R. Eckman, J. P. Scott, W. C. Mentzer, S. C. Davies, K. Ohene-Frempong, F. Bernaudin, D. C. Matthews, et al. 1996. Bone marrow transplantation for sickle cell disease. N. Engl. J. Med. 335: 369-376. (Pubitemid 26257244)
9. Ren, H., J. Shen, C. Tomiyama-Miyaji, M. Watanabe, E. Kainuma, M. Inoue, Y. Kuwano, and T. Abo. 2006. Augmentation of innate immunity by low-dose irradiation. Cell. Immunol. 244: 50-56. (Pubitemid 46659716)
10. Paulos, C. M., C. Wrzesinski, A. Kaiser, C. S. Hinrichs, M. Chieppa, L. Cassard, D. C. Palmer, A. Boni, P. Muranski, Z. Yu, et al. 2007. Microbial translocation augments the function of adoptively transferred self/tumor-specific CD8+ T cells via TLR4 signaling. J. Clin. Invest. 117: 2197-2204. (Pubitemid 47219564)
11. Anderson, B. E., J. M. McNiff, C. Matte, I. Athanasiadis, W. D. Shlomchik, and M. J. Shlomchik. 2004. Recipient CD4+ T cells that survive irradiation regulate chronic graft-versus-host disease. Blood 104: 1565-1573. (Pubitemid 39166539)
12. Yao, Z., Y. Liu, J. Jones, and S. Strober. 2009. Differences in Bcl-2 expression by T-cell subsets alter their balance after in vivo irradiation to favor CD4+Bcl-2hi NKT cells. Eur. J. Immunol. 39: 763-775.
13. Higuchi, M., D. Zeng, J. Shizuru, J. Gworek, S. Dejbakhsh-Jones, M. Taniguchi, and S. Strober. 2002. Immune tolerance to combined organ and bone marrow transplants after fractionated lymphoid irradiation involves regulatory NK T cells and clonal deletion. J. Immunol. 169: 5564-5570. (Pubitemid 35291655)
14. Nador, R. G., D. Hongo, J. Baker, Z. Yao, and S. Strober. 2010. The changed balance of regulatory and naive T cells promotes tolerance after TLI and anti-T-cell antibody conditioning. Am. J. Transplant. 10: 262-272.
15. Tamada, K., M. Harada, K. Abe, T. Li, and K. Nomoto. 1998. IL-4-producing NK1.1+ T cells are resistant to glucocorticoid-induced apoptosis: implications for the Th1/Th2 balance. J. Immunol. 161: 1239-1247. (Pubitemid 28380550)
16. Seino, K., M. Harada, and M. Taniguchi. 2004. NKT cells are relatively resistant to apoptosis. Trends Immunol. 25: 219-221. (Pubitemid 38501666)
17. Lan, F., D. Zeng, M. Higuchi, P. Huie, J. P. Higgins, and S. Strober. 2001. Predominance of NK1.1+TCR alpha beta+ or DX5+TCR alpha beta+ T cells in mice conditioned with fractionated lymphoid irradiation protects against graft-versus-host disease: "natural suppressor" cells. J. Immunol. 167: 2087-2096. (Pubitemid 32747517)
18. Kohrt, H. E., B. B. Turnbull, K. Heydari, J. A. Shizuru, G. G. Laport, D. B. Miklos, L. J. Johnston, S. Arai, W. K. Weng, R. T. Hoppe, et al. 2009. TLI and ATG conditioning with low risk of graft-versus-host disease retains antitumor reactions after allogeneic hematopoietic cell transplantation from related and unrelated donors. Blood 114: 1099-1109.
19. Belka, C., and W. Budach. 2002. Anti-apoptotic Bcl-2 proteins: structure, function and relevance for radiation biology. Int. J. Radiat. Biol. 78: 643-658. (Pubitemid 34971768)
20. Lee, J. M., and A. Bernstein. 1993. p53 mutations increase resistance to ionizing radiation. Proc. Natl. Acad. Sci. USA 90: 5742-5746. (Pubitemid 23176238)
21. Lowe, S. W., E. M. Schmitt, S. W. Smith, B. A. Osborne, and T. Jacks. 1993. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature 362: 847-849. (Pubitemid 23132161)
22. Pillai, A. B., T. I. George, S. Dutt, P. Teo, and S. Strober. 2007. Host NKT cells can prevent graft-versus-host disease and permit graft antitumor activity after bone marrow transplantation. J. Immunol. 178: 6242-6251. (Pubitemid 46717407)
23. Kang, S. M., Q. Tang, and J. A. Bluestone. 2007. CD4+CD25+ regulatory T cells in transplantation: progress, challenges and prospects. Am. J. Transplant. 7: 1457-1463. (Pubitemid 46776267)
24. Lan, F., D. Zeng, M. Higuchi, J. P. Higgins, and S. Strober. 2003. Host conditioning with total lymphoid irradiation and antithymocyte globulin prevents graft-versus-host disease: the role of CD1-reactive natural killer T cells. Biol. Blood Marrow Transplant. 9: 355-363. (Pubitemid 38351806)
25. Sakaguchi, S. 2005. Naturally arising Foxp3-expressing CD25+CD4+ regulatory T cells in immunological tolerance to self and non-self. Nat. Immunol. 6: 345-352. (Pubitemid 41716771)
26. Wood, K. J., and S. Sakaguchi. 2003. Regulatory T cells in transplantation tolerance. Nat. Rev. Immunol. 3: 199-210. (Pubitemid 37323205)
27. Zeng, D., D. Lewis, S. Dejbakhsh-Jones, F. Lan, M. García-Ojeda, R. Sibley, and S. Strober. 1999. Bone marrow NK1.1(-) and NK1.1(+) T cells reciprocally regulate acute graft versus host disease. J. Exp. Med. 189: 1073-1081. (Pubitemid 29169824)
28. Brown, J. M., and L. D. Attardi. 2005. The role of apoptosis in cancer development and treatment response. Nat. Rev. Cancer 5: 231-237. (Pubitemid 40314954)
29. Villunger, A., E. M. Michalak, L. Coultas, F. Müllauer, G. Böck, M. J. Ausserlechner, J. M. Adams, and A. Strasser. 2003. p53- and drug-induced apoptotic responses mediated by BH3-only proteins puma and noxa. Science 302: 1036-1038. (Pubitemid 37386194)
30. Erlacher, M., E. M. Michalak, P. N. Kelly, V. Labi, H. Niederegger, L. Coultas, J. M. Adams, A. Strasser, and A. Villunger. 2005. BH3-only proteins Puma and Bim are rate-limiting for gamma-radiation- and glucocorticoid-induced apoptosis of lymphoid cells in vivo. Blood 106: 4131-4138. (Pubitemid 41775918)
31. Grayson, J. M., A. J. Zajac, J. D. Altman, and R. Ahmed. 2000. Cutting edge: increased expression of Bcl-2 in antigen-specific memory CD8+ T cells. J. Immunol. 164: 3950-3954. (Pubitemid 30215046)
32. Kurtulus, S., P. Tripathi, M. E. Moreno-Fernandez, A. Sholl, J. D. Katz, H. L. Grimes, and D. A. Hildeman. 2011. Bcl-2 Allows Effector and Memory CD8+ T Cells To Tolerate Higher Expression of Bim. J. Immunol.
33. Boise, L. H., A. J. Minn, P. J. Noel, C. H. June, M. A. Accavitti, T. Lindsten, and C. B. Thompson. 1995. CD28 costimulation can promote T cell survival by enhancing the expression of Bcl-XL. Immunity 3: 87-98.